<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC6835697/table_5" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 5</label>
  <p>HIV-1 resistance mechanisms against GRFT.</p>
 </caption>
 <thead>
  <tr>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-0-.">HIV Type</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-1-.">Cell Line</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-2-.">Assay Readout</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-3-.">Resistance Mechanism</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" id="0-4-.">Ref.</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 subtype C primary virus isolates</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TZM-bl and PBMC</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 neutralization assay</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Loss of glycans at positions 234 and 295</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B25-marinedrugs-17-00567" ref-type="bibr">25</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Primary and T-cell-line-adapted HIV-1 isolates</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TZM-bl cells</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Env-pseudotyped viruses to infect TZM-bl cells</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Loss of glycan at position 295 and 448</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B40-marinedrugs-17-00567" ref-type="bibr">40</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 subtype C primary virus isolates</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Raji/DC-SIGN cells</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The DC-SIGN-mediated HIV-1 transfer to TZM-bl cells</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Introduction of a glycan at position 234</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B38-marinedrugs-17-00567" ref-type="bibr">38</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 subtype C primary virus isolates</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TheTZM-bl and PBMC</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 neutralization assay in PBMC</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Loss of glycan at positions 230, 234, 339, 392, and 448</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B39-marinedrugs-17-00567" ref-type="bibr">39</a>] 
   </td>
  </tr>
  <tr>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single transmitted/founder HIV-1</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TZM-bl cells</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutralization assay using pseudotyped viruses</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Loss of glycan at positions 295, 339, and 448</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[ 
    <a rid="B31-marinedrugs-17-00567" ref-type="bibr">31</a>] 
   </td>
  </tr>
 </tbody>
</table>
